血管内取栓术中临时近端血流阻断(ProFATE):一项多中心、盲法终点、随机临床试验
ProFATE试验在英国4个取栓中心纳入134例前循环大血管闭塞急性缺血性卒中患者,随机分为临时近端血流阻断组与非血流阻断组,主要终点为取栓结束时的近完全/完全血管再通(eTICI 2c-3)。结果显示两组主要终点无显著差异(74.4% vs 70.8%;校正OR 1.07,95%CI 0.45-2.55;P=0.88)。血流阻断组新血管区域栓塞率更低(1.5% vs 12.3%),首次尝试后完全再通率更高(33.0% vs 15.3%)。
要点
- 临时近端血流阻断未显著提高取栓结束时的eTICI 2c-3再通率(74.4% vs 70.8%;校正OR 1.07;P=0.88)。
- 血流阻断组新血管区域栓塞率更低(1.5% vs 12.3%;校正OR 0.04;P=0.014)。
- 血流阻断组首次尝试后完全再通率更高(33.0% vs 15.3%;校正OR 3.80;P=0.007)。
核心结论
- 在前循环大血管闭塞急性缺血性卒中患者中,取栓术中临时近端血流阻断与非血流阻断相比,未显著改善取栓结束时的近完全/完全血管再通(eTICI 2c-3)。
- 需要更大规模的随机对照试验来证实或否定临时血流阻断对取栓术后功能结局的临床显著治疗效应。
研究设计与样本
- ProFATE试验是一项在英国4个取栓中心开展的多中心、参与者和结局盲法的随机临床试验。
- 纳入因前循环大血管闭塞导致急性缺血性卒中的成人患者,按1:1随机分配至每次取栓尝试时采用临时近端血流阻断或非血流阻断。
- 随机化通过中央网络程序结合最小化算法进行。
- 主要终点为取栓结束时达到近完全/完全血管再通(eTICI 2c或3)的参与者比例,由盲法独立影像核心实验室判定。
- 分析基于意向治疗人群,校正年龄、静脉溶栓、发病至随机化时间、ASPECTS、闭塞部位、随机化中心和NIHSS。
主要发现
- 2021年10月10日至2023年6月27日共招募134例参与者,最终分析纳入131例(平均年龄75岁;女性62例[47%],男性69例[53%])。
- 血流阻断组66例,非血流阻断组65例。
- 取栓结束时eTICI 2c/3比例:血流阻断组74.4%(49/66) vs 非血流阻断组70.8%(46/65);校正OR 1.07(95%CI 0.45-2.55);P=0.88。
- 新血管区域栓塞率:血流阻断组1.5% vs 非血流阻断组12.3%;校正OR 0.04(95%CI 0.01-0.53);P=0.014。
- 首次尝试后完全再通(eTICI 3)率:血流阻断组33.0% vs 非血流阻断组15.3%;校正OR 3.80(95%CI 1.40-10.01);P=0.007。
关键数值与推荐
- 主要终点eTICI 2c-3比例:血流阻断组74.4%(49/66) vs 非血流阻断组70.8%(46/65),校正OR 1.07(95%CI 0.45-2.55),P=0.88。
- 新血管区域栓塞率:血流阻断组1.5% vs 非血流阻断组12.3%,校正OR 0.04(95%CI 0.01-0.53),P=0.014。
- 首次尝试后eTICI 3完全再通率:血流阻断组33.0% vs 非血流阻断组15.3%,校正OR 3.80(95%CI 1.40-10.01),P=0.007。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The effect of temporary blood flow arrest during endovascular thrombectomy for acute ischemic stroke is uncertain due to the lack of evidence from randomized controlled trials. We aimed to investigate whether temporary blood flow arrest during endovascular thrombectomy using a balloon guide catheter improves intracranial vessel recanalization compared with nonflow arrest. METHODS: The ProFATE trial (Proximal Blood Flow Arrest During Endovascular Thrombectomy) was a multicenter, randomized, participant- and outcome-blinded trial at 4 thrombectomy centers in the United Kingdom. Adults with acute ischemic stroke due to anterior circulation large vessel occlusion were randomly assigned (1:1) by a central, Web-based program with a minimization algorithm to undergo thrombectomy with temporary proximal blood flow arrest or nonflow arrest during each attempt. The primary outcome was the proportion of participants achieving near-complete/complete vessel recanalization (expanded Thrombolysis in Cerebral Infarction score of 2c or 3) at the end of the thrombectomy procedure, adjudicated by a blinded independent imaging core laboratory. Analyses were performed on the intention-to-treat population, adjusted for age, IV thrombolysis, onset-to-randomization time, Alberta Stroke Program Early CT Score, occlusion site, randomization site, and National Institutes of Health Stroke Scale. RESULTS: Between October 10, 2021, and June 27, 2023, we recruited 134 participants, of whom 131 participants (mean age, 75 years; 62 [47%] women and 69 [53%] men) were included in the final analysis. Sixty-six participants were allocated to the temporary blood flow arrest group and 65 to the nonflow arrest group. The proportion of participants with an expanded Thrombolysis in Cerebral Infarction 2c/3 score at the end of the endovascular procedure was 74.4% (49/66) in the flow arrest group and 70.8% (46/65) in the nonflow arrest group (adjusted odds ratio, 1.07 [95% CI, 0.45-2.55]; P=0.88). Among the prespecified secondary efficacy outcomes, a lower rate of emboli to a new vascular territory occurred in the blood flow arrest group compared with the nonflow arrest group (1.5% versus 12.3%; adjusted odds ratio, =0.04 [95% CI, 0.01-0.53]; P=0.014) and a higher rate of complete recanalization (expanded Thrombolysis in Cerebral Infarction score, 3) after the first attempt in the flow arrest group versus the nonflow arrest group (33.0% versus 15.3%; adjusted odds ratio, =3.80 [95% CI, 1.40-10.01]; P=0.007). No between-group differences were identified for the remaining procedural or clinical efficacy (modified Rankin Scale at 90 days) or safety outcomes (worsening of the stroke severity at 24 hours, adverse events, symptomatic intracranial hemorrhage, or mortality). CONCLUSIONS: Among patients presenting with anterior circulation large vessel occlusion acute ischemic stroke, temporary proximal blood flow arrest during endovascular thrombectomy, compared with nonflow arrest, did not significantly improve the near-complete/complete vessel recanalization (expanded Thrombolysis in Cerebral Infarction score, 2c-3) at the end of the procedure. Larger randomized controlled trials are warranted to confirm or refute a clinically significant treatment effect of temporary flow arrest on the functional outcome following endovascular thrombectomy. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT05020795.
引用
- Dhillon PS, Butt W, Podlasek A, et al. Effect of Proximal Blood Flow Arrest During Endovascular Thrombectomy (ProFATE): A Multicenter, Blinded-End Point, Randomized Clinical Trial. Stroke. 2024. PMID: 39697177. doi:10.1161/STROKEAHA.124.049715
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。